NEW YORK, Dec. 26, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Imaging Biomarkers market has also been witnessing the emergence of personalized medicines. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market.
TechNavio's report, the Global Imaging Biomarkers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Imaging Biomarkers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Abbott Laboratories, Agilent Technologies Inc., Affymetrix Inc., Bio-Rad Laboratories Inc., F. Hoffmann La Roche Ltd., Gen-Probe Inc., and Siemens Healthcare.
Key questions answered in this report:
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Geographical Segmentation
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Key Vendors
15.3 Market Share Analysis 2013
16. Key Vendor Analysis
16.1 Abbott Laboratories
16.1.1 Business Overview
16.1.2 Business Segmentation
16.1.3 Key Information
16.1.4 SWOT Analysis
16.2 Affymetrix Inc.
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Bio-Rad Laboratories Inc.
16.3.1 Business Overview
16.3.2 Business Segmentation
16.3.3 Key Information
16.3.4 SWOT Analysis
16.4 F. Hoffmann La Roche Ltd.
16.4.1 Business Overview
16.4.2 Business Segmentation
16.4.3 Key Information
16.4.4 SWOT Analysis
16.5 Siemens Healthcare
16.5.1 Business Overview
16.5.2 Key Information
16.5.3 SWOT Analysis
17. Other Reports in this Series
Exhibit 1: Market Research Methodology
Exhibit 2: Global Imaging Biomarkers Market 2013-2018 (US$ billion)
Exhibit 3: Global Imaging Biomarkers Market by Geographical Segmentation 2013
Exhibit 4: Business Segmentation of Abbott Laboratories
Exhibit 5: Business Segmentation of Affymetrix Inc.
Exhibit 6: Business Segmentation of Bio-Rad Laboratories Inc.
Exhibit 7: Business Segmentation of F. Hoffmann La Roche Ltd.
Abbott Laboratories, Agilent Technologies Inc., Affymetrix Inc., Bio-Rad Laboratories Inc., F. Hoffmann La Roche Ltd., Gen-Probe Inc., and Siemens Healthcare.
To order this report: Global Imaging Biomarkers Market 2014-2018
Contact Clare: email@example.com
Intl: +1 339-368-6001